SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,752.17 288.75
(0.60%)

Dow Jones

6,952.35 21.56
(0.31%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.57 -0.04
(-0.05%)

EUR-INR

105.52 0.34
(0.32%)

GBP-INR

120.86 0.52
(0.43%)

JPY-INR

0.57 0.00
(0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

140.8744507

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

17001.29

EPS(TTM)

Face Value()

Div & Yield %

0.47

Back

Advik Capital consolidated net profit declines 80.57% in the June 2025 quarter

Aug 21,2025

Net profit of Advik Capital declined 80.57% to Rs 0.48 crore in the quarter ended June 2025 as against Rs 2.47 crore during the previous quarter ended June 2024. Sales declined 96.75% to Rs 7.41 crore in the quarter ended June 2025 as against Rs 227.79 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	7.41	227.79	-97
OPM %	67.34	2.09	-
PBDT	1.56	3.19	-51
PBT	1.37	3.05	-55
NP	0.48	2.47	-81

85,041.45 -367.25 ( -0.43%)

48,752.17 288.75 (0.60%)

6,952.35 21.56 (0.31%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.57 -0.04 (-0.05%)

105.52 0.34 (0.32%)

120.86 0.52 (0.43%)

0.57 0.00 (0.60%)